edd/Vaccine

Standard method for detecting upper respiratory carriage of Streptococcus pneumoniae: updated recommendations from the World Health Organization Pneumococcal Carriage Working Group.Satzke C, Turner P, Virolainen-Julkunen A, Adrian PV, Antonio M, Hare KM, Henao-Restrepo AM, Leach AJ, Klugman KP, Porter BD, Sa-Leao R, Scott JA, Nohynek H, O'Brien KL, WHO Pneumococcal Carriage Working Group
Vaccine, (2013). 32:165-79

Strategic priorities for respiratory syncytial virus (RSV) vaccine development.Anderson LJ, Dormitzer PR, Nokes DJ, Rappuoli R, Roca A, Graham BS
Vaccine, (2013). 31 Suppl 2:B209-15

Spatial and socio-demographic predictors of time-to-immunization in a rural area in Kenya: Is equity attainable?.Moisi JC, Kabuka J, Mitingi D, Levine OS, Scott JA
Vaccine, (2010). 28:5725-30

Evaluation of a measles vaccine campaign in Ethiopia using oral-fluid antibody surveys.Nigatu W, Samuel D, Cohen B, Cumberland P, Lemma E, Brown DW, Nokes J
Vaccine, (2008). 26:4769-74

Mathematical model of the antibody response to hepatitis B vaccines: implications for reduced schedules.Wilson JN, Nokes DJ, Medley GF, Shouval D
Vaccine, (2007). 25:3705-12

The preventable burden of pneumococcal disease in the developing world.Scott JA
Vaccine, (2007). 25:2398-405

High levels of serum antibodies to merozoite surface protein 2 of Plasmodium falciparum are associated with reduced risk of clinical malaria in coastal Kenya.Polley SD, Conway DJ, Cavanagh DR, McBride JS, Lowe BS, Williams TN, Mwangi TW, Marsh K
Vaccine, (2006). 24:4233-46

Human antibodies to recombinant protein constructs of Plasmodium falciparum Apical Membrane Antigen 1 (AMA1) and their associations with protection from malaria.Polley SD, Mwangi T, Kocken CH, Thomas AW, Dutta S, Lanar DE, Remarque E, Ross A, Williams TN, Mwambingu G, Lowe B, Conway DJ, Marsh K
Vaccine, (2004). 23:718-28